Dr. Roy Jensen, director of The University of Kansas Cancer Center, talks about new studies of how COVID affects cancer patients and what role genetic markers in the disease. Also, Dr. Ronald Chen on whether we’re catching up on cancer screenings after COVID brought a huge drop in those vital tests.